News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jones William Benton
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/20/2022 |
4
| Jones William Benton (See Remarks) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Bought 20,000 shares
@ $0.79, valued at
$15.8k
|
|
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Jones William Benton (See Remarks) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 160,000 options to buy
@ $4.01, valued at
$641.6k
|
|
| 12/16/2019 |
4
| Jones William Benton (See Remarks) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 160,000 options to buy
@ $3.54, valued at
$566.4k
|
|
| 12/14/2018 |
4
| Jones William Benton (See Remarks) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.94, valued at
$594k
|
|
| 12/15/2017 |
4
| Jones William Benton (See Remarks) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $10.6, valued at
$424k
|
|
| 12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/24/2016 |
4
| Jones William Benton (VP Pharmaceutical Development) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $15, valued at
$900k
|
|
|
|